Obesity and fertility.
Hormone Molecular Biology and Clinical Investigation
|September 10, 2015
Summary
Obesity in women of reproductive age is linked to infertility and ovulatory issues. While weight loss may improve conception, its effect on live birth rates requires further research.
Area of Science:
- Reproductive Endocrinology
- Obesity Medicine
- Infertility Research
Background:
- Increasing prevalence of overweight and obesity in women of reproductive age over the last 30 years.
- Infertility affects approximately 1 in 7 couples, with female obesity being a significant contributing factor.
- Obesity is associated with ovulatory dysfunction, potentially impacting fertility.
Purpose of the Study:
- To explore the mechanisms linking female obesity to delayed time to pregnancy (TTP).
- To review the impact of weight loss on conception and live birth rates in women undergoing fertility treatments.
- To examine the association between the obesity epidemic and male infertility, including hormonal and semen parameter effects.
Main Methods:
- Literature review and synthesis of existing research on obesity, infertility, and reproductive outcomes.
- Analysis of studies investigating the effects of excess body fat on ovulation, oocyte quality, embryo development, and endometrial receptivity.
- Examination of data on the efficacy of weight loss interventions on fertility and live birth rates.
- Review of evidence linking male obesity to hormonal disturbances and compromised semen parameters.
Main Results:
- Female obesity contributes to infertility through ovulatory problems, impaired oocyte quality, reduced embryo development, and altered endometrial function.
- Weight loss in women has demonstrated improvements in conception rates.
- The impact of weight loss on live birth rates following fertility treatment is less clear and warrants further investigation.
- The rise in obesity correlates with potential increases in male infertility, linked to hormonal imbalances and poor semen quality.
Conclusions:
- Female obesity presents a multifaceted challenge to fertility, affecting ovulation, gamete and embryo quality, and uterine receptivity.
- Interventions aimed at weight reduction in women may enhance the likelihood of conception.
- Further research is crucial to determine the definitive impact of weight loss on live birth rates in assisted reproductive technologies.
- The concurrent rise in male infertility suggests a need for comprehensive research into the effects of obesity on male reproductive health.
More Related Videos
Related Concept Videos
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients
341
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
341
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
384
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
384
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
284
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
284
Infertility in Males
683
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
683
Infertility in Females
5.0K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
5.0K


